Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

116 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The sialyltransferase ST3GAL6 influences homing and survival in multiple myeloma.
Glavey SV, Manier S, Natoni A, Sacco A, Moschetta M, Reagan MR, Murillo LS, Sahin I, Wu P, Mishima Y, Zhang Y, Zhang W, Zhang Y, Morgan G, Joshi L, Roccaro AM, Ghobrial IM, O'Dwyer ME. Glavey SV, et al. Blood. 2014 Sep 11;124(11):1765-76. doi: 10.1182/blood-2014-03-560862. Epub 2014 Jul 24. Blood. 2014. PMID: 25061176 Free PMC article. Clinical Trial.
Proteomic characterization of human multiple myeloma bone marrow extracellular matrix.
Glavey SV, Naba A, Manier S, Clauser K, Tahri S, Park J, Reagan MR, Moschetta M, Mishima Y, Gambella M, Rocci A, Sacco A, O'Dwyer ME, Asara JM, Palumbo A, Roccaro AM, Hynes RO, Ghobrial IM. Glavey SV, et al. Leukemia. 2017 Nov;31(11):2426-2434. doi: 10.1038/leu.2017.102. Epub 2017 Mar 27. Leukemia. 2017. PMID: 28344315
The cancer glycome: carbohydrates as mediators of metastasis.
Glavey SV, Huynh D, Reagan MR, Manier S, Moschetta M, Kawano Y, Roccaro AM, Ghobrial IM, Joshi L, O'Dwyer ME. Glavey SV, et al. Blood Rev. 2015 Jul;29(4):269-79. doi: 10.1016/j.blre.2015.01.003. Epub 2015 Jan 23. Blood Rev. 2015. PMID: 25636501 Review.
AKT as a therapeutic target in multiple myeloma.
Keane NA, Glavey SV, Krawczyk J, O'Dwyer M. Keane NA, et al. Expert Opin Ther Targets. 2014 Aug;18(8):897-915. doi: 10.1517/14728222.2014.924507. Epub 2014 Jun 6. Expert Opin Ther Targets. 2014. PMID: 24905897 Review.
Targeting the Pim kinases in multiple myeloma.
Keane NA, Reidy M, Natoni A, Raab MS, O'Dwyer M. Keane NA, et al. Blood Cancer J. 2015 Jul 17;5(7):e325. doi: 10.1038/bcj.2015.46. Blood Cancer J. 2015. PMID: 26186558 Free PMC article. Review.
The CD38low natural killer cell line KHYG1 transiently expressing CD16F158V in combination with daratumumab targets multiple myeloma cells with minimal effector NK cell fratricide.
Sarkar S, Chauhan SKS, Daly J, Natoni A, Fairfield H, Henderson R, Nolan E, Swan D, Hu J, Reagan MR, O'Dwyer M. Sarkar S, et al. Cancer Immunol Immunother. 2020 Mar;69(3):421-434. doi: 10.1007/s00262-019-02477-8. Epub 2020 Jan 9. Cancer Immunol Immunother. 2020. PMID: 31919623 Free PMC article.
116 results